0001209191-18-009672.txt : 20180213 0001209191-18-009672.hdr.sgml : 20180213 20180213172155 ACCESSION NUMBER: 0001209191-18-009672 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180209 FILED AS OF DATE: 20180213 DATE AS OF CHANGE: 20180213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANNING MARTHA E CENTRAL INDEX KEY: 0001227894 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 18604964 MAIL ADDRESS: STREET 1: 700 PENNSYLVANIA DR CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-09 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001227894 MANNING MARTHA E C/O ACHILLION PHARMACEUTICALS, INC. 300 GEORGE STREET NEW HAVEN CT 06511 0 1 0 0 General Counsel Employee Stock Option 2.90 2018-02-09 4 A 0 215000 0.00 A 2028-02-09 Common Stock 215000 215000 D This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. /s/ Martha Manning 2018-02-13